SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients

BACKGROUND: The involvement of SARS-CoV-2 antibodies in mediating immunopathogenetic events in COVID-19 patients has been suggested. By using several experimental approaches, we investigated the potential association between SARS-CoV-2 IgGs recognizing the spike (S) protein receptor-binding domain (...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Virol
Auteurs principaux: Gozalbo-Rovira, Roberto, Gimenez, Estela, Latorre, Víctor, Francés-Gómez, Clara, Albert, Eliseo, Buesa, Javier, Marina, Alberto, Blasco, María Luisa, Signes-Costa, Jaime, Rodríguez-Díaz, Jesús, Geller, Ron, Navarro, David
Format: Artigo
Langue:Inglês
Publié: Elsevier B.V. 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7459327/
https://ncbi.nlm.nih.gov/pubmed/32882666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2020.104611
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires